Price T Rowe Associates Inc. MD Boosts Stake in Molina Healthcare, Inc $MOH

Price T Rowe Associates Inc. MD grew its stake in shares of Molina Healthcare, Inc (NYSE:MOH) by 46.4% during the 1st quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 3,838,043 shares of the company’s stock after buying an additional 1,216,903 shares during the quarter. Price T Rowe Associates Inc. MD owned 7.08% of Molina Healthcare worth $1,264,214,000 at the end of the most recent quarter.

Other institutional investors and hedge funds have also recently made changes to their positions in the company. Teacher Retirement System of Texas purchased a new stake in shares of Molina Healthcare during the 1st quarter valued at $2,759,000. Farther Finance Advisors LLC grew its holdings in shares of Molina Healthcare by 100.3% during the 1st quarter. Farther Finance Advisors LLC now owns 659 shares of the company’s stock valued at $216,000 after purchasing an additional 330 shares during the last quarter. Robeco Institutional Asset Management B.V. bought a new position in shares of Molina Healthcare during the 1st quarter valued at $1,070,000. Wealth Enhancement Advisory Services LLC grew its holdings in shares of Molina Healthcare by 82.1% during the 1st quarter. Wealth Enhancement Advisory Services LLC now owns 15,635 shares of the company’s stock valued at $5,150,000 after purchasing an additional 7,051 shares during the last quarter. Finally, Wealthcare Advisory Partners LLC bought a new position in shares of Molina Healthcare during the 1st quarter valued at $255,000. Hedge funds and other institutional investors own 98.50% of the company’s stock.

Insider Activity

In related news, Director Ronna Romney sold 700 shares of the business’s stock in a transaction dated Wednesday, August 6th. The shares were sold at an average price of $153.74, for a total transaction of $107,618.00. Following the transaction, the director owned 17,131 shares in the company, valued at $2,633,719.94. The trade was a 3.93% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, COO James Woys purchased 10,000 shares of Molina Healthcare stock in a transaction that occurred on Monday, August 4th. The shares were bought at an average price of $155.94 per share, for a total transaction of $1,559,400.00. Following the transaction, the chief operating officer directly owned 74,331 shares of the company’s stock, valued at $11,591,176.14. This trade represents a 15.54% increase in their ownership of the stock. The disclosure for this purchase can be found here. 1.10% of the stock is owned by insiders.

Molina Healthcare Price Performance

MOH stock opened at $172.6480 on Friday. The firm’s 50-day moving average price is $213.50 and its two-hundred day moving average price is $278.05. Molina Healthcare, Inc has a 12-month low of $151.95 and a 12-month high of $365.23. The stock has a market capitalization of $9.36 billion, a price-to-earnings ratio of 8.51 and a beta of 0.52. The company has a current ratio of 1.66, a quick ratio of 1.66 and a debt-to-equity ratio of 0.77.

Molina Healthcare (NYSE:MOH) last released its quarterly earnings data on Wednesday, July 23rd. The company reported $5.48 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $5.50 by ($0.02). Molina Healthcare had a net margin of 2.60% and a return on equity of 27.72%. The firm had revenue of $11.43 billion during the quarter, compared to analysts’ expectations of $10.94 billion. During the same quarter in the previous year, the firm posted $5.86 EPS. Molina Healthcare’s revenue was up 15.7% compared to the same quarter last year. As a group, equities analysts predict that Molina Healthcare, Inc will post 24.4 earnings per share for the current year.

Wall Street Analyst Weigh In

Several research firms recently commented on MOH. Morgan Stanley lowered shares of Molina Healthcare from an “overweight” rating to an “equal weight” rating and reduced their target price for the company from $364.00 to $266.00 in a report on Thursday, July 10th. JPMorgan Chase & Co. reduced their target price on shares of Molina Healthcare from $272.00 to $184.00 and set a “neutral” rating on the stock in a report on Tuesday, July 29th. Wall Street Zen lowered shares of Molina Healthcare from a “buy” rating to a “hold” rating in a report on Sunday, June 29th. Robert W. Baird reduced their target price on shares of Molina Healthcare from $373.00 to $179.00 and set a “neutral” rating on the stock in a report on Friday, July 25th. Finally, UBS Group reduced their target price on shares of Molina Healthcare from $260.00 to $180.00 and set a “neutral” rating on the stock in a report on Friday, July 25th. Three research analysts have rated the stock with a Buy rating and ten have assigned a Hold rating to the company’s stock. Based on data from MarketBeat.com, Molina Healthcare has an average rating of “Hold” and a consensus target price of $242.91.

Molina Healthcare Company Profile

Molina Healthcare, Inc provides managed healthcare services to low-income families and individuals under the Medicaid and Medicare programs and through the state insurance marketplaces. It operates in four segments: Medicaid, Medicare, Marketplace, and Other. The company served in across 19 states. The company was founded in 1980 and is headquartered in Long Beach, California.